Cargando…
Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847656/ https://www.ncbi.nlm.nih.gov/pubmed/33531981 http://dx.doi.org/10.7150/jca.52349 |
_version_ | 1783644967332216832 |
---|---|
author | Fu, Junyi Li, Yanli Wu, Lisha Yang, Xin Quan, Tingting Li, Xi Zeng, Jiamin Deng, Yinhui Yu, Jinxiu |
author_facet | Fu, Junyi Li, Yanli Wu, Lisha Yang, Xin Quan, Tingting Li, Xi Zeng, Jiamin Deng, Yinhui Yu, Jinxiu |
author_sort | Fu, Junyi |
collection | PubMed |
description | Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treated with GKRS were retrospectively reviewed in a single center. There were 271 male (36.1%) and 480 female (63.9%) patients with a median age of 38.5 (range, 7.2-84.0) years. The number of nonfunctioning pituitary adenomas (NFPAs) and functioning pituitary adenomas were 369 (49.1%) and 382 (50.9%) respectively. The median follow-up time was 61.1 (range, 12.1-304.4) months. Results: In this study, 88 patients (11.7%) were diagnosed with pituitary hemorrhage before GKRS, 55 patients (7.3%) developed new or worsened pituitary hemorrhage after GKRS (excluding 3 patients with new or worsened pituitary hemorrhage due to tumor regrowth). The median time to new or worsened pituitary hemorrhage after GKRS was 18.9 (range 3.1-70.7) months. Overall, 128 patients (17.0%) were diagnosed with pituitary hemorrhage in the entire series. After adjustment with logistic regression, nonfunctioning pituitary adenomas (NFPAs) (odds ratio [OR]=2.121, 95% confidence interval [CI]=1.195-3.763, p=0.010) and suprasellar extension (OR=2.470, 95% CI=1.361-4.482, p=0.003) were associated with pituitary hemorrhage before GKRS. NFPA (OR=3.271, 95% CI=1.278-8.373, p=0.013) was associated with new or worsened pituitary hemorrhage after GKRS. Five patients received surgical resection for new or worsened pituitary hemorrhage were considered as GKRS treatment failure. Two patients with new hypopituitarism were considered to be owed to new or worsened pituitary hemorrhage after GKRS. Conclusions: New or worsened pituitary hemorrhage after GKRS was not an uncommon phenomenon. NFPA was an independent risk factor of new or worsened pituitary hemorrhage after GKRS. New or worsened pituitary hemorrhage after GKRS could lead to GKRS treatment failure. GKRS might be a precipitating factor of pituitary hemorrhage. |
format | Online Article Text |
id | pubmed-7847656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-78476562021-02-01 Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis Fu, Junyi Li, Yanli Wu, Lisha Yang, Xin Quan, Tingting Li, Xi Zeng, Jiamin Deng, Yinhui Yu, Jinxiu J Cancer Research Paper Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treated with GKRS were retrospectively reviewed in a single center. There were 271 male (36.1%) and 480 female (63.9%) patients with a median age of 38.5 (range, 7.2-84.0) years. The number of nonfunctioning pituitary adenomas (NFPAs) and functioning pituitary adenomas were 369 (49.1%) and 382 (50.9%) respectively. The median follow-up time was 61.1 (range, 12.1-304.4) months. Results: In this study, 88 patients (11.7%) were diagnosed with pituitary hemorrhage before GKRS, 55 patients (7.3%) developed new or worsened pituitary hemorrhage after GKRS (excluding 3 patients with new or worsened pituitary hemorrhage due to tumor regrowth). The median time to new or worsened pituitary hemorrhage after GKRS was 18.9 (range 3.1-70.7) months. Overall, 128 patients (17.0%) were diagnosed with pituitary hemorrhage in the entire series. After adjustment with logistic regression, nonfunctioning pituitary adenomas (NFPAs) (odds ratio [OR]=2.121, 95% confidence interval [CI]=1.195-3.763, p=0.010) and suprasellar extension (OR=2.470, 95% CI=1.361-4.482, p=0.003) were associated with pituitary hemorrhage before GKRS. NFPA (OR=3.271, 95% CI=1.278-8.373, p=0.013) was associated with new or worsened pituitary hemorrhage after GKRS. Five patients received surgical resection for new or worsened pituitary hemorrhage were considered as GKRS treatment failure. Two patients with new hypopituitarism were considered to be owed to new or worsened pituitary hemorrhage after GKRS. Conclusions: New or worsened pituitary hemorrhage after GKRS was not an uncommon phenomenon. NFPA was an independent risk factor of new or worsened pituitary hemorrhage after GKRS. New or worsened pituitary hemorrhage after GKRS could lead to GKRS treatment failure. GKRS might be a precipitating factor of pituitary hemorrhage. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7847656/ /pubmed/33531981 http://dx.doi.org/10.7150/jca.52349 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Fu, Junyi Li, Yanli Wu, Lisha Yang, Xin Quan, Tingting Li, Xi Zeng, Jiamin Deng, Yinhui Yu, Jinxiu Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title | Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title_full | Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title_fullStr | Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title_full_unstemmed | Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title_short | Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
title_sort | pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847656/ https://www.ncbi.nlm.nih.gov/pubmed/33531981 http://dx.doi.org/10.7150/jca.52349 |
work_keys_str_mv | AT fujunyi pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT liyanli pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT wulisha pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT yangxin pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT quantingting pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT lixi pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT zengjiamin pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT dengyinhui pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis AT yujinxiu pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis |